| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |